Nu Skin Enterprises (NUS) 10-Q 8 May 14 2014 Q1 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	3 Months Ended
In Billions, except Share data, unless otherwise specified	Mar. 31, 2014	Jan. 31, 2014	Jun. 28, 2013
Document and Entity Information [Abstract]	'	'	'
Entity Registrant Name	'NU SKIN ENTERPRISES INC	'	'
Entity Central Index Key	'0001021561	'	'
Current Fiscal Year End Date	'--12-31	'	'
Entity Well-known Seasoned Issuer	'Yes	'	'
Entity Voluntary Filers	'No	'	'
Entity Current Reporting Status	'Yes	'	'
Entity Filer Category	'Large Accelerated Filer	'	'
Entity Public Float	'	'	$3.50
Entity Common Stock, Shares Outstanding	'	58,949,802	'
Document Fiscal Year Focus	'2014	'	'
Document Fiscal Period Focus	'Q1	'	'
Document Type	'10-Q	'	'
Amendment Flag	'false	'	'
Document Period End Date	31-Mar-14	'	'

Consolidated_Balance_Sheets_Un

Consolidated Balance Sheets (Unaudited) (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Current assets:	'	'
Cash and cash equivalents	$284,580	$525,153
Current investments	18,703	21,974
Accounts receivable	56,644	68,652
Inventories, net	410,668	339,669
Prepaid expenses and other	149,523	162,886
Total current assets	920,118	1,118,334
Property and equipment, net	411,929	396,042
Goodwill	112,446	112,446
Other intangible assets, net	81,377	83,168
Other assets	115,751	111,072
Total assets	1,641,621	1,821,062
Current liabilities:	'	'
Accounts payable	51,276	82,684
Accrued expenses	449,434	626,284
Current portion of long-term debt	88,031	67,824
Total current liabilities	588,741	776,792
Long-term debt	109,882	113,852
Other liabilities	79,418	71,799
Total liabilities	778,041	962,443
Commitments and contingencies (Note 9)	'	'
Stockholders' equity:	'	'
Class A common stock - 500 million shares authorized, $.001 par value, 90.6 million shares issued	91	91
Additional paid-in capital	399,677	397,383
Treasury stock, at cost - 31.7 million and 32.2 million shares	-848,335	-826,904
Accumulated other comprehensive loss	-66,250	-46,228
Retained earnings	1,378,397	1,334,277
Total stockholders' equity	863,580	858,619
Total liabilities and stockholders' equity	$1,641,621	$1,821,062

Consolidated_Balance_Sheets_Un1

Consolidated Balance Sheets (Unaudited) Parenthetical (USD $)	Mar. 31, 2014	Dec. 31, 2013
In Millions, except Per Share data, unless otherwise specified
Stockholders' equity:	'	'
Common stock - authorized (in shares)	500	500
Common stock - par value (in dollars per share)	$0.00	$0.00
Common stock - issued (in shares)	90.6	90.6
Treasury stock, at cost (in shares)	31.6	31.6

Consolidated_Statements_of_Inc

Consolidated Statements of Income (Unaudited) (USD $)	3 Months Ended
In Thousands, except Share data in Millions, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Consolidated Statements of Income (Unaudited) [Abstract]	'	'
Revenue	$671,061	$541,305
Cost of sales	106,644	90,045
Gross profit	564,417	451,260
Operating expenses:	'	'
Selling expenses	313,101	233,094
General and administrative expenses	150,119	135,507
Total operating expenses	463,220	368,601
Operating income	101,197	82,659
Other income (expense), net	-3,604	112
Income before provision for income taxes	97,593	82,771
Provision for income taxes	33,332	28,489
Net income	$64,261	$54,282
Net income per share (Note 2):	'	'
Basic (in dollars per share)	$1.09	$0.93
Diluted (in dollars per share)	$1.05	$0.90
Weighted-average common shares outstanding (000s):	'	'
Basic (in shares)	58,869	58,352
Diluted (in shares)	61,227	60,566

Consolidated_Statements_of_Com

Consolidated Statements of Comprehensive Income (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Consolidated Statements of Comprehensive Income [Abstract]	'	'
Net Income (Loss) Attributable to Parent	$64,261	$54,282
Other Comprehensive Income (Loss), Net of Tax [Abstract]	'	'
Foreign currency translation adjustment	-19,528	-3,373
Net unrealized gains/(losses) on foreign currency cash flow hedges	-257	986
Less: Reclassification adjustment for realized losses/gains in current earnings	-237	-1,163
Total	-20,022	-3,550
Comprehensive Income	$44,239	$50,732

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Cash flows from operating activities:	'	'
Net income	$64,261	$54,282
Adjustments to reconcile net income to net cash provided by operating activities:	'	'
Depreciation and amortization	12,251	7,612
Foreign currency (gains)/losses	3,445	-336
Stock-based compensation	8,682	5,712
Deferred taxes	9,023	2,826
Changes in operating assets and liabilities:	'	'
Accounts receivable	11,597	-8,048
Inventories, net	-76,730	-15,995
Prepaid expenses and other	9,533	-9,997
Other assets	-3,752	-7,553
Accounts payable	-30,692	5,528
Accrued expenses	-166,830	32,920
Other liabilities	-1,388	3,435
Net cash provided by operating activities	-160,600	70,386
Cash flows from investing activities:	'	'
Purchases of property and equipment	-30,538	-41,239
Proceeds of investment sales	12,638	4,844
Purchases of investments	-9,556	0
Net cash used in investing activities	-27,456	-36,395
Cash flows from financing activities:	'	'
Exercise of employee stock options	-8,375	-268
Payment of debt	-5,834	-7,816
Payment of cash dividends	-20,141	-17,514
Income tax benefit of options exercised	5,610	2,245
Proceeds from debt	20,000	20,000
Repurchases of shares of common stock	-25,002	-14,615
Net cash used in financing activities	-33,742	-17,968
Effect of exchange rate changes on cash	-18,775	-10,328
Net increase in cash and cash equivalents	-240,573	5,695
Cash and cash equivalents, beginning of period	525,153	320,025
Cash and cash equivalents, end of period	$284,580	$325,720

THE_COMPANY

THE COMPANY	3 Months Ended
	Mar. 31, 2014
THE COMPANY [Abstract]	'
THE COMPANY	'
	1	THE COMPANY
	Nu Skin Enterprises, Inc. (the "Company") is a leading, global direct selling company that develops and distributes premium-quality, innovative personal care products and nutritional supplements that are sold worldwide under the Nu Skin and Pharmanex brands and a small number of other products and services. Over the last five years, the Company has introduced new Pharmanex nutritional supplements and Nu Skin personal care products un der its ageLOC anti-aging brand. The Company reports revenue from five geographic regions:  Greater China, which consists of Mainland China, Hong Kong, Macau and Taiwan; North Asia, which consists of Japan and South Korea; South Asia/Pacific, which consists of Australia, Brunei, French Polynesia, Indonesia, Malaysia, New Caledonia, New Zealand, the Philippines, Singapore, Thailand and Vietnam; Americas, which consists of the United States, Canada and Latin America; and Europe, Middle East and Africa ("EMEA"), which consists of several markets in Europe as well as Israel, Russia and South Africa (the Company's subsidiaries operating in these countries are collectively referred to as the "Subsidiaries").
	The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X.  Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements.  The unaudited consolidated financial statements include the accounts of the Company and its Subsidiaries.  All significant intercompany accounts and transactions are eliminated in consolidation.  In the opinion of management, the accompanying unaudited consolidated financial statements contain all adjustments, consisting of normal recurring adjustments, considered necessary for a fair statement of the Company's financial information as of March 31, 2014, and for the three-month periods ended March 31, 2014 and 2013. The results of operations of any interim period are not necessarily indicative of the results of operations to be expected for the fiscal year. For further information, refer to the consolidated financial statements and accompanying footnotes included in the Company's Annual Report on Form 10-K for the year ended December 31, 2013.

NET_INCOME_PER_SHARE

NET INCOME PER SHARE	3 Months Ended
	Mar. 31, 2014
NET INCOME PER SHARE [Abstract]	'
NET INCOME PER SHARE	'
	2	NET INCOME PER SHARE
	Net income per share is computed based on the weighted-average number of common shares outstanding during the periods presented. Additionally, diluted earnings per share data gives effect to all potentially dilutive common shares that were outstanding during the periods presented. For the three-month periods ended March 31, 2014 and 2013, other stock options totaling 2.0 million and 0.3 million, respectively were excluded from the calculation of diluted earnings per share because they were anti-dilutive.

DIVIDENDS_PER_SHARE

DIVIDENDS PER SHARE	3 Months Ended
	Mar. 31, 2014
DIVIDENDS PER SHARE [Abstract]	'
DIVIDENDS PER SHARE	'
	3	DIVIDENDS PER SHARE
	In March 2014, the Company's board of directors declared a quarterly cash dividend of $0.345 per share. This quarterly cash dividend totaling $20.1 million was paid on March 26, 2014, to stockholders of record on March 14, 2014. In May 2014, the Company's board of directors declared a quarterly cash dividend of $0.345 per share to be paid June 11, 2014 to stockholders of record on May 23, 2014.

DERIVATIVE_FINANCIAL_INSTRUMEN

DERIVATIVE FINANCIAL INSTRUMENTS	3 Months Ended
	Mar. 31, 2014
DERIVATIVE FINANCIAL INSTRUMENTS [Abstract]	'
DERIVATIVE FINANCIAL INSTRUMENTS	'
	4	DERIVATIVE FINANCIAL INSTRUMENTS
	The Company held mark-to-market forward contracts designated as foreign currency cash flow hedges with notional amounts totaling 2.9 billion Japanese yen and 11.0 million euros ($28.0 million and $15.1 million, respectively) as of March 31, 2014 and 1.1 billion Japanese yen ($11.7 million) and no euros as of March 31, 2013 to hedge forecasted foreign-currency-denominated intercompany transactions.
	The contracts held at March 31, 2014 have maturities through February 2015 and accordingly, all unrealized gains and losses on foreign currency cash flow hedges included in accumulated other comprehensive income will be recognized in current earnings over the next 12 months. The pre-tax net gains on foreign currency cash flow hedges reclassified from accumulated other comprehensive income to revenue were $- million and $0.4 million for the    . The corresponding tax effects of these transactions were recorded in provision for income tax expense. As of March 31, 2014 and December 31, 2013, there were $0.8 million and $1.3 million of unrealized gains included in accumulated other comprehensive income related to foreign currency cash flow hedges. The remaining $67.0 million and $47.5 million as of March 31, 2014 and December 31, 2013, respectively, in accumulated other comprehensive income are related to cumulative translation adjustments.

REPURCHASES_OF_COMMON_STOCK

REPURCHASES OF COMMON STOCK	3 Months Ended
	Mar. 31, 2014
REPURCHASES OF COMMON STOCK [Abstract]	'
REPURCHASES OF COMMON STOCK	'
	5	REPURCHASES OF COMMON STOCK
	During the three-month periods ended March 31, 2014 and 2013, the Company repurchased approximately 0.3 million and 0.4 million shares of its Class A common stock under its open market repurchase plan for approximately $25.0 million and $14.6 million, respectively. At March 31, 2014, $369.5 million was available for repurchases under the stock repurchase program.

SEGMENT_INFORMATION

SEGMENT INFORMATION	3 Months Ended
	Mar. 31, 2014
SEGMENT INFORMATION [Abstract]	'
SEGMENT INFORMATION	'
	6	SEGMENT INFORMATION
	The Company operates in a single operating segment by selling products through a global network of independent distributors that operates in a seamless manner from market to market, except for its operations in Mainland China. In Mainland China, the Company utilizes sales employees, contractual sales promoters, and independent direct sellers to distribute its products.  Contractual sales promoters sell products in similar fashion to the Company's sales employees, but act as independent agents to sell products through its retail stores and website.  Independent direct sellers can sell away from the Company's stores in jurisdictions where the Company has obtained a direct sales license to do so. Selling expenses are the Company's largest expense comprised of the commissions paid to its worldwide independent distributors as well as remuneration to its sales force in Mainland China. The Company manages its business primarily by managing its sales force.  The Company does not use profitability reports on a regional or divisional basis for making business decisions.  However, the Company does report revenue in five geographic regions: Greater China, North Asia, Americas, South Asia/Pacific and EMEA.
	Revenue generated in each of these regions is set forth below (U.S. dollars in thousands):
			Three Months Ended
			March 31,
	Revenue:		2014		2013
	Greater China	$	278,929	$	170,822
	North Asia		195,461		185,910
	Americas		79,909		75,692
	South Asia/Pacific		71,194		66,957
	EMEA		45,568		41,924
	Total	$	671,061	$	541,305
	Revenue generated by each of the Company's product lines is set forth below (U.S. dollars in thousands):
			Three Months Ended
			March 31,
	Revenue:		2014		2013
	Nu Skin	$	402,111	$	321,440
	Pharmanex		267,272		218,351
	Other		1,678		1,514
	Total	$	671,061	$	541,305
	Additional information as to the Company's operations in its most significant geographic areas is set forth below (U.S. dollars in thousands):
			Three Months Ended
			March 31,
	Revenue:		2014		2013
	Mainland China	$	212,217	$	119,665
	South Korea		114,000		81,095
	Japan		81,461		104,815
	United States		54,822		56,886
	Taiwan		35,764		32,126
	Hong Kong		30,948		19,031
	Malaysia		19,049		18,043
	Long-lived assets:		31-Mar-14		31-Dec-13
	Mainland China	$	89,967	$	82,726
	South Korea		21,660		14,345
	Japan		11,261		9,970
	United States		274,489		273,388
	Taiwan		1,938		1,928
	Hong Kong		2,352		2,497
	Malaysia		1,327		1,463

DEFERRED_TAX_ASSETS_AND_LIABIL

DEFERRED TAX ASSETS AND LIABILITIES	3 Months Ended
	Mar. 31, 2014
DEFERRED TAX ASSETS AND LIABILITIES [Abstract]	'
DEFERRED TAX ASSETS AND LIABILITIES	'
	7	DEFERRED TAX ASSETS AND LIABILITIES
	The Company accounts for income taxes in accordance with the Income Taxes Topic of the Financial Accounting Standards Codification.  These standards establish financial accounting and reporting standards for the effects of income taxes that result from an enterprise's activities during the current and preceding years.  The Company takes an asset and liability approach for financial accounting and reporting of income taxes.  The Company pays income taxes in many foreign jurisdictions based on the profits realized in those jurisdictions, which can be significantly impacted by terms of intercompany transactions between the Company and its foreign affiliates.  Deferred tax assets and liabilities are created in this process.  As of March 31, 2014, the Company has netted these deferred tax assets of $56.7 million. The Company nets these deferred tax assets and deferred tax liabilities by jurisdiction. Valuation allowances are established when necessary to reduce deferred tax assets to the amounts expected to be ultimately realized.
	The Company evaluates its indefinite reinvestment assertions with respect to foreign earnings for each quarter.  Other than earnings the Company intends to reinvest indefinitely, the Company accrues for the U.S. federal, state and foreign income tax applicable to the earnings.  Undistributed earnings that the Company has indefinitely reinvested, and for which no federal income taxes in the U.S. have been provided, aggregate to $50.0 million at March 31, 2014 and December 31, 2013.  In the event that all non-U.S. subsidiaries' undistributed earnings, which the Company has designated as indefinitely reinvested, were remitted to the United States to fund operating and capital plans, regulatory capital requirements parent company financing or cash flow needs, the amount of incremental taxes would be approximately $5.5 million.

UNCERTAIN_TAX_POSITIONS

UNCERTAIN TAX POSITIONS	3 Months Ended
	Mar. 31, 2014
UNCERTAIN TAX POSITIONS [Abstract]	'
UNCERTAIN TAX POSITIONS	'
	8	UNCERTAIN TAX POSITIONS
	The Company files income tax returns in the U.S. federal jurisdiction, and in various state and foreign jurisdictions.  The Company is no longer subject to tax examinations from the United States Internal Revenue Service (the "IRS") for any years for which tax returns have been filed except for 2011.  With a few exceptions, the Company is no longer subject to state and local income tax examination by tax authorities for the years before 2008.  In 2009, the Company entered into a voluntary program with the IRS called Compliance Assurance Process ("CAP"). The objective of CAP is to contemporaneously work with the IRS to achieve federal tax compliance and resolve all or most of the issues prior to filing of the tax return.  The Company has elected to participate in the CAP program for 2014 and may elect to continue participating in CAP for future tax years; the Company may withdraw from the program at any time.  In major foreign jurisdictions, the Company is no longer subject to income tax examinations for years before 2007. Along with the IRS examination of 2011, the Company is currently under examination in certain foreign jurisdictions; however, the outcomes of those reviews are not yet determinable.
	The Company's unrecognized tax benefits relate to multiple foreign and domestic jurisdictions.  Due to potential increases in unrecognized tax benefits from the multiple jurisdictions in which the Company operates, as well as the expiration of various statutes of limitation, it is reasonably possible that the Company's gross unrecognized tax benefits, net of foreign currency adjustments, may decrease within the next 12 months by a range of approximately $3 to $4 million.

COMMITMENTS_AND_CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	3 Months Ended
	Mar. 31, 2014
COMMITMENTS AND CONTINGENCIES [Abstract]	'
COMMITMENTS AND CONTINGENCIES	'
	9	COMMITMENTS AND CONTINGENCIES
	The Company is subject to governmental regulations pertaining to product formulation, labeling and packaging, product claims and advertising and to the Company's direct selling system.  The Company is also subject to the jurisdiction of numerous foreign tax and customs authorities.  Any assertions or determination that either the Company or the Company's sales force is not in compliance with existing statutes, laws, rules or regulations could potentially have a material adverse effect on the Company's operations.  In addition, in any country or jurisdiction, the adoption of new statutes, laws, rules or regulations or changes in the interpretation of existing statutes, laws, rules or regulations could have a material adverse effect on the Company and its operations.  Although management believes that the Company is in compliance in all material respects with the statutes, laws, rules and regulations of every jurisdiction in which it operates, no assurance can be given that the Company's compliance with applicable statutes, laws, rules and regulations will not be challenged by foreign authorities or that such challenges will not have a material adverse effect on the Company's financial position or results of operations or cash flows.  The Company and its Subsidiaries are defendants in litigation and proceedings involving various matters.  Except as noted below, in the opinion of the Company's management, based upon advice of its counsel handling such litigation and proceedings, adverse outcomes, if any, will not likely result in a material effect on the Company's consolidated financial condition, results of operations or cash flows.
	The Company is subject to regular audits by federal, state and foreign tax authorities.  These audits may result in additional tax liabilities.  The Company believes it has appropriately provided for income taxes for all years.  Several factors drive the calculation of its tax reserves.  Some of these factors include: (i) the expiration of various statutes of limitations; (ii) changes in tax law and regulations; (iii) issuance of tax rulings; and (iv) settlements with tax authorities. Changes in any of these factors may result in adjustments to the Company's reserves, which would impact its reported financial results.
	The Company is currently involved in a dispute related to customs assessments on several of the Company's products made by Yokohama Customs for the period of October 2006 through September 2009 in connection with post-importation audits, as well as the disputed portion of the Company's import duties from October 2009 to the present, which the Company has or will hold in bond or pay under protest.  Additional assessments related to any prior period are barred by applicable statutes of limitations. The aggregate amount of these assessments and disputed duties was approximately 4.2 billion Japanese yen as of March 31, 2014 (approximately $40.3 million), net of any recovery of consumption taxes.  The issue in this case is whether a United States entity utilizing a commissionaire agent in Japan to import its products can use the manufacturer's invoice or must use another valuation method, and, if an alternative method must be used, what the allowable deductions would be in determining the proper valuation.  Following the Company's review of the assessments and after consulting with the Company's legal and customs advisors, the Company believes that the additional assessments are improper and are not supported by applicable customs laws. The Company filed letters of protest with the applicable Customs authorities, which were rejected. The Company then appealed the matter to the Ministry of Finance in Japan. In the second quarter of 2011, the Ministry of Finance in Japan denied the Company's administrative appeal. The Company disagrees with the Ministry of Finance's administrative decision. The Company is now pursuing the matter in Tokyo District Court, which the Company believes will provide a more independent determination of the matter. In addition, the Company is currently being required to post a bond or make a deposit to secure any additional duties that may be due and payable on these current imports.  Because the Company believes that the assessment of higher duties by the customs authorities is an improper application of the regulations, the Company is currently expensing the portion of the duties the Company believes is supported under applicable customs law, and recording the additional deposit or payment as a receivable within long-term assets on its consolidated financial statements. If the Company is unsuccessful in recovering the amounts assessed and paid, the Company will record a non-cash expense for the full amount of the disputed assessments. The Company anticipates that additional disputed duties will be limited going forward as the Company has entered into an arrangement to purchase a majority of the affected products in Japan from a Japanese company that purchases and imports the products from the manufacturers.
	In addition, the Company is currently being sued in several purported class action lawsuits and derivative claims relating to negative media and regulatory scrutiny regarding the Company's business in Mainland China and the associated decline in the Company's stock price.  These lawsuits, or others filed alleging similar facts, could result in monetary or other penalties that may affect the Company's operating results and financial condition.
	Additionally, in April 2014, the Company responded to a stockholder demand from the Trustees of the Laborers' International Union of North America Local 235 Annuity Fund, seeking to inspect certain corporate records pursuant to Delaware General Corporation Law Section 220.

LONG_TERM_DEBT

LONG TERM DEBT	3 Months Ended
	Mar. 31, 2014
LONG TERM DEBT [Abstract]	'
LONG TERM DEBT	'
	10	LONG-TERM DEBT
	The Company currently has debt pursuant to various credit facilities and other borrowings.  The following table summarizes the Company's long-term debt arrangements:
	Facility or		Original Principal Amount		Balance as of		Balance as of	Interest Rate	Repayment terms
	Arrangement				March 31, 2014(1)		December 31, 2013
	Multi-currency uncommitted shelf facility(2):
	U.S. dollar denominated:		$40.0 million	$	17.1 million	$	17.1 million	6.20%	Notes due July 2016 with annual principal payments that began in July 2010.
			$20.0 million	$	8.6 million	$	11.4 million	6.20%	Notes due January 2017 with annual principal payments that began in January 2011.
	Japanese yen denominated:		3.1 billion yen		0.4 billion yen or $4.3 million		0.4 billion yen or $4.1 million	1.70%	Notes due April 2014 with annual principal payments that began in April 2008.(3)
			2.3 billion yen		1.3 billion yen or $12.6 million		1.3 billion yen or $12.3 million	2.60%	Notes due September 2017 with annual principal payments that began in September 2011.
			2.2 billion yen		0.9 billion yen or $9.0 million		1.2 billion yen or $11.8 million	3.30%	Notes due January 2017 with annual principal payments that began in January 2011.
			8.0 billion yen		8.0 billion yen or $77.3 million		8.0 billion yen or $75.8 million	1.70%	Notes due May 2022 with annual principal payments that begin in May 2016.
	Revolving credit facilities(4)(5):
	2010				$35.0 million		$35,000,000.0 million	Variable 30 day: 0.66%	Revolving line of credit.
	2013				$34.0 million		$14,000,000.0 million	Variable 30 day: 0.5843%	Revolving line of credit.
	-1	The current portion of the Company's long-term debt (i.e. becoming due in the next 12 months) includes $10.4 million of the balance of its Japanese yen-denominated debt under the multi-currency uncommitted shelf facility, $8.6 million of the balance on its U.S. dollar denominated debt under the multi-currency uncommitted shelf facility and $69.0 million of the Company's revolving loans.
	-2	On May 6, 2014, the Company entered into a third amendment of the amended and restated note purchase and private shelf agreement (multi-currency), dated as of May 25, 2012, among the Company, Prudential Investment Management, Inc. and certain other purchasers. The amendment modified the restricted payments covenant to allow the aggregate amount of restricted payments to exceed the allowed threshold by no more than $50 million for the quarter ending March 31, 2014, $100 million for the quarter ending June 30, 2014 and $50 million for the quarter ending September 30, 2014, to avoid default or acceleration provisions of the agreement.
	-3	On April 30, 2014, the Company paid the notes in full.
	-4	On April 9, 2014, the Company entered into an additional 364 day revolving line of credit with Bank of America, N.A. with a commitment amount of $50.0 million. The interest rate is equal to 1 month LIBOR plus 95.0 basis points.
	-5	On May 6, 2014, the Company entered into a fifth amendment of the amended and restated credit agreement, dated as of May 25, 2012, among the Company, various financial institutions, and JPMorgan Chase Bank, N.A. as administrative agent.  The amendment modified the restricted payments covenant to allow the aggregate amount of restricted payments to exceed the allowed threshold by no more than $50 million for the quarter ending March 31, 2014, $100 million for the quarter ending June 30, 2014 and $50 million for the quarter ending September 30, 2014, to avoid default or acceleration provisions of the agreement. The amendment also fixed the applicable interest rate at LIBOR plus 0.75%, increased the commitment fee to 0.25% and extended the term of the agreement from May 9, 2014 to August 8, 2014, with $15 million reductions in the commitment amount on June 30, 2014 and July 31, 2014.

ACCOUNTING_PRONOUNCEMENTS

ACCOUNTING PRONOUNCEMENTS	3 Months Ended
	Mar. 31, 2014
Accounting Pronouncements [Abstract]	'
Accounting Pronouncements	'
	11	ACCOUNTING PRONOUNCEMENTS
	In July 2013, the FASB issued ASU No. 2013-11, Income Taxes (Topic 740): Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists (a consensus of the Emerging Issues Task Force). This ASU addresses when unrecognized tax benefits should be presented as reductions to deferred tax assets for net operating loss carryforwards in the financial statements. This ASU is effective prospectively for fiscal years, and interim periods within those years, beginning after December 15, 2013. The adoption of ASU 2013-11 did not have a material impact on the Company's consolidated financial position, results of operations or cash flows.

REVISIONS

REVISIONS	3 Months Ended
	Mar. 31, 2014
REVISIONS [Abstract]	'
REVISIONS [Text Block]	'
	12.      REVISIONS
	The presentation of the Company's consolidated statements of income for the first quarter of 2013 was revised to reduce the selling expense and revenue by $8.8 million related to an error in the classification of selling rebates.  The revision had no effect on the operating income, net income or comprehensive income, the consolidated balance sheet or cash flows.  The revision was not considered to be material to the previously issued financial statements.

SUBSEQUENT_EVENT

SUBSEQUENT EVENT	3 Months Ended
	Mar. 31, 2014
SUBSEQUENT EVENT [Abstract]	'
SUBSEQUENT EVENT [Text Block]	'
	13.      SUBSEQUENT EVENT
	As of March 31, 2014, the Company was in violation of its restricted payments covenant under its amended and restated credit agreement, dated as of May 25, 2012, among the Company, various financial institutions, and JPMorgan Chase Bank, N.A. as administrative agent, as amended (the "JPMC Agreement") and its amended and restated note purchase and private shelf agreement (multi-currency), dated as of May 25, 2012, among the Company, Prudential Investment Management, Inc. and certain other purchasers, as amended (the "Prudential Agreement"), which restricts the company from making dividend payments or stock repurchases to the extent the aggregate amount of such payments exceed $100 million plus the cumulative cash flow from operations less capital investments since June 30, 2012. Effective May 6, 2014, the Company entered into amendments of the JPMC Agreement and the Prudential Agreement that allow the aggregate amount of restricted payments to exceed the allowed threshold by no more than $50 million for the quarter ending March 31, 2014, $50 million for the quarter ending June 30, 2014 and $50 million for the quarter ending September 30, 2014, to avoid default or acceleration provisions of these agreements. The amendment of the JPMC Agreement also fixed the applicable interest rate at LIBOR plus 0.75%, increased the commitment fee to 0.25% and extended the term of the agreement from May 9, 2014 to August 8, 2014, with $15 million reductions in the commitment amount on June 30, 2014 and July 31, 2014.

SEGMENT_INFORMATION_Tables

SEGMENT INFORMATION (Tables)	3 Months Ended
	Mar. 31, 2014
SEGMENT INFORMATION [Abstract]	'
Revenue and Long-Lived Assets by Geographic Region	'
	Revenue generated in each of these regions is set forth below (U.S. dollars in thousands):
			Three Months Ended
			March 31,
	Revenue:		2014		2013
	Greater China	$	278,929	$	170,822
	North Asia		195,461		185,910
	Americas		79,909		75,692
	South Asia/Pacific		71,194		66,957
	EMEA		45,568		41,924
	Total	$	671,061	$	541,305
Revenue Generated by Each of the Company's Major Product Lines	'
	Revenue generated by each of the Company's product lines is set forth below (U.S. dollars in thousands):
			Three Months Ended
			March 31,
	Revenue:		2014		2013
	Nu Skin	$	402,111	$	321,440
	Pharmanex		267,272		218,351
	Other		1,678		1,514
	Total	$	671,061	$	541,305
Revenue and long-lived assets by significant geographic area	'
	Additional information as to the Company's operations in its most significant geographic areas is set forth below (U.S. dollars in thousands):
			Three Months Ended
			March 31,
	Revenue:		2014		2013
	Mainland China	$	212,217	$	119,665
	South Korea		114,000		81,095
	Japan		81,461		104,815
	United States		54,822		56,886
	Taiwan		35,764		32,126
	Hong Kong		30,948		19,031
	Malaysia		19,049		18,043
	Long-lived assets:		31-Mar-14		31-Dec-13
	Mainland China	$	89,967	$	82,726
	South Korea		21,660		14,345
	Japan		11,261		9,970
	United States		274,489		273,388
	Taiwan		1,938		1,928
	Hong Kong		2,352		2,497
	Malaysia		1,327		1,463

LONG_TERM_DEBT_Tables

LONG TERM DEBT (Tables)	3 Months Ended
	Mar. 31, 2014
LONG TERM DEBT [Abstract]	'
Summary of Long-Term Debt Arrangements	'
	The Company currently has debt pursuant to various credit facilities and other borrowings.  The following table summarizes the Company's long-term debt arrangements:
	Facility or		Original Principal Amount		Balance as of		Balance as of	Interest Rate	Repayment terms
	Arrangement				March 31, 2014(1)		December 31, 2013
	Multi-currency uncommitted shelf facility(2):
	U.S. dollar denominated:		$40.0 million	$	17.1 million	$	17.1 million	6.20%	Notes due July 2016 with annual principal payments that began in July 2010.
			$20.0 million	$	8.6 million	$	11.4 million	6.20%	Notes due January 2017 with annual principal payments that began in January 2011.
	Japanese yen denominated:		3.1 billion yen		0.4 billion yen or $4.3 million		0.4 billion yen or $4.1 million	1.70%	Notes due April 2014 with annual principal payments that began in April 2008.(3)
			2.3 billion yen		1.3 billion yen or $12.6 million		1.3 billion yen or $12.3 million	2.60%	Notes due September 2017 with annual principal payments that began in September 2011.
			2.2 billion yen		0.9 billion yen or $9.0 million		1.2 billion yen or $11.8 million	3.30%	Notes due January 2017 with annual principal payments that began in January 2011.
			8.0 billion yen		8.0 billion yen or $77.3 million		8.0 billion yen or $75.8 million	1.70%	Notes due May 2022 with annual principal payments that begin in May 2016.
	Revolving credit facilities(4)(5):
	2010				$35.0 million		$35,000,000.0 million	Variable 30 day: 0.66%	Revolving line of credit.
	2013				$34.0 million		$14,000,000.0 million	Variable 30 day: 0.5843%	Revolving line of credit.
	-1	The current portion of the Company's long-term debt (i.e. becoming due in the next 12 months) includes $10.4 million of the balance of its Japanese yen-denominated debt under the multi-currency uncommitted shelf facility, $8.6 million of the balance on its U.S. dollar denominated debt under the multi-currency uncommitted shelf facility and $69.0 million of the Company's revolving loans.
	-2	On May 6, 2014, the Company entered into a third amendment of the amended and restated note purchase and private shelf agreement (multi-currency), dated as of May 25, 2012, among the Company, Prudential Investment Management, Inc. and certain other purchasers. The amendment modified the restricted payments covenant to allow the aggregate amount of restricted payments to exceed the allowed threshold by no more than $50 million for the quarter ending March 31, 2014, $100 million for the quarter ending June 30, 2014 and $50 million for the quarter ending September 30, 2014, to avoid default or acceleration provisions of the agreement.
	-3	On April 30, 2014, the Company paid the notes in full.
	-4	On April 9, 2014, the Company entered into an additional 364 day revolving line of credit with Bank of America, N.A. with a commitment amount of $50.0 million. The interest rate is equal to 1 month LIBOR plus 95.0 basis points.
	-5	On May 6, 2014, the Company entered into a fifth amendment of the amended and restated credit agreement, dated as of May 25, 2012, among the Company, various financial institutions, and JPMorgan Chase Bank, N.A. as administrative agent.  The amendment modified the restricted payments covenant to allow the aggregate amount of restricted payments to exceed the allowed threshold by no more than $50 million for the quarter ending March 31, 2014, $100 million for the quarter ending June 30, 2014 and $50 million for the quarter ending September 30, 2014, to avoid default or acceleration provisions of the agreement. The amendment also fixed the applicable interest rate at LIBOR plus 0.75%, increased the commitment fee to 0.25% and extended the term of the agreement from May 9, 2014 to August 8, 2014, with $15 million reductions in the commitment amount on June 30, 2014 and July 31, 2014.

THE_COMPANY_Details

THE COMPANY (Details)	3 Months Ended
	Mar. 31, 2014
	Region
THE COMPANY [Abstract]	'
Number of geographic regions	5

NET_INCOME_PER_SHARE_Details

NET INCOME PER SHARE (Details)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
NET INCOME PER SHARE [Abstract]	'	'
Other shares excluded from the calculation of diluted earnings per share (in shares)	2	0.3

DIVIDENDS_PER_SHARE_Details

DIVIDENDS PER SHARE (Details) (USD $)	3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 31, 2014	Sep. 30, 2013	Mar. 31, 2013
DIVIDENDS PER SHARE [Abstract]	'	'	'
Date declared	'2014-03	'2014-05	'
Cash dividend declared (in dollars per share)	$0.35	$0.35	'
Payment of cash dividends	$20,141	'	$17,514
Date paid	26-Mar-14	11-Jun-14	'
Date of record	14-Mar-14	23-May-14	'

DERIVATIVE_FINANCIAL_INSTRUMEN1

DERIVATIVE FINANCIAL INSTRUMENTS (Details)	Mar. 31, 2014	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2014	Mar. 31, 2014	Dec. 31, 2013	Mar. 31, 2014	Dec. 31, 2013
In Millions, unless otherwise specified	USD ($)	JPY (¥)	USD ($)	JPY (¥)	Forward Contracts - Yen [Member]	Forward Contracts - Euros [Member]	Foreign Currency Cash Flow Hedges [Member]	Foreign Currency Cash Flow Hedges [Member]	Foreign Currency Translation Adjustment [Member]	Foreign Currency Translation Adjustment [Member]
					USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Derivative [Line Items]	'	'	'	'	'	'	'	'	'	'
Notional amount of foreign currency cash flow hedges	$11	¥ 2,900	$11.70	¥ 1,100	$28	$15.10	'	'	'	'
Currency bought	'	'	'	'	'Japanese yen	'euros	'	'	'	'
Net unrealized gain	'	'	0.4	'	'	'	'	'	'	'
Unrealized gains included in accumulated other comprehensive income	'	'	'	'	'	'	$0.80	$1.30	$67	$47.50

REPURCHASES_OF_COMMON_STOCK_De

REPURCHASES OF COMMON STOCK (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Equity, Class of Treasury Stock [Line Items]	'	'
Common stock repurchased (in shares)	0.3	0.4
Common stock repurchased	$25	$14.60
Available for repurchase under the repurchase program	$369.50	'

SEGMENT_INFORMATION_Details

SEGMENT INFORMATION (Details) (USD $)

3 Months Ended

3 Months Ended

3 Months Ended

3 Months Ended

3 Months Ended

3 Months Ended

3 Months Ended

In Thousands, unless otherwise specified

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2014

Mar. 31, 2013

Dec. 31, 2013

Mar. 31, 2014

Mar. 31, 2013

Dec. 31, 2013

Mar. 31, 2013

Sep. 30, 2012

Mar. 31, 2014

Dec. 31, 2013

Mar. 31, 2014

Mar. 31, 2013

Dec. 31, 2013

Mar. 31, 2014

Mar. 31, 2013

Dec. 31, 2013

Mar. 31, 2013

Sep. 30, 2012

Mar. 31, 2014

Dec. 31, 2013

Mar. 31, 2013

Sep. 30, 2012

Mar. 31, 2014

Dec. 31, 2013

ProductLine

North Asia [Member]

North Asia [Member]

Greater China [Member]

Greater China [Member]

Americas [Member]

Americas [Member]

South Asia/Pacific [Member]

South Asia/Pacific [Member]

Europe - By Region [Member]

Europe - By Region [Member]

Japan [Member]

Japan [Member]

Japan [Member]

South Korea [Member]

South Korea [Member]

South Korea [Member]

Hong Kong [Member]

Hong Kong [Member]

Hong Kong [Member]

Hong Kong [Member]

United States [Member]

United States [Member]

United States [Member]

Mainland China [Member]

Mainland China [Member]

Mainland China [Member]

Taiwan [Member]

Taiwan [Member]

Taiwan [Member]

Taiwan [Member]

Malaysia [Member]

Malaysia [Member]

Malaysia [Member]

Malaysia [Member]

Region

SEGMENT INFORMATION [Abstract]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of geographic regions

5

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of product lines

3

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Revenues from External Customers and Long-Lived Assets [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Revenue

$671,061

$541,305

$195,461

$185,910

$278,929

$170,822

$71,194

$66,957

$79,909

$75,692

$45,568

$41,924

$114,000

$81,095

'

$81,461

$104,815

'

$30,948

$19,031

'

'

$54,822

$56,886

'

$212,217

$119,665

'

$35,764

$32,126

'

'

$19,049

$18,043

'

'

Long-lived assets

'

'

'

'

'

'

'

'

'

'

'

'

$21,660

'

$14,345

$11,261

'

$9,970

'

'

$2,352

$2,497

$274,489

'

$273,388

$89,967

'

$82,726

'

'

$1,938

$1,928

'

'

$1,327

$1,463

SEGMENT_INFORMATION_Products_a

SEGMENT INFORMATION, Products and Services (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Revenue from External Customer [Line Items]	'	'
Revenue	$671,061	$541,305
Nu Skin [Member]	'	'
Revenue from External Customer [Line Items]	'	'
Revenue	402,111	321,440
Pharmanex [Member]	'	'
Revenue from External Customer [Line Items]	'	'
Revenue	267,272	218,351
Other Product Lines [Member]	'	'
Revenue from External Customer [Line Items]	'	'
Revenue	$1,678	$1,514

DEFERRED_TAX_ASSETS_AND_LIABIL1

DEFERRED TAX ASSETS AND LIABILITIES (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014
DEFERRED TAX ASSETS AND LIABILITIES [Abstract]	'
Net deferred tax assets	$56.70
Foreign earnings indefinitely reinvested, during the period	$50

UNCERTAIN_TAX_POSITIONS_Detail

UNCERTAIN TAX POSITIONS (Details) (USD $)	Mar. 31, 2014
In Millions, unless otherwise specified
UNCERTAIN TAX POSITIONS [Abstract]	'
Estimate of change in gross unrecognized tax benefits, net of foreign currency adjustments, within the next 12 months - minimum	$3
Estimate of change in gross unrecognized tax benefits, net of foreign currency adjustments, within the next 12 months - maximum	$4

COMMITMENTS_AND_CONTINGENCIES_

COMMITMENTS AND CONTINGENCIES (Details)	Mar. 31, 2014	Mar. 31, 2014
In Millions, unless otherwise specified	USD ($)	JPY (¥)
Loss Contingencies [Line Items]	'	'
Aggregate amount of assessments and disputed duties	$40.30	¥ 4,200

LONG_TERM_DEBT_Details

LONG TERM DEBT (Details)

3 Months Ended

3 Months Ended

3 Months Ended

3 Months Ended

3 Months Ended

3 Months Ended

3 Months Ended

3 Months Ended

Mar. 31, 2014

Mar. 31, 2014

Dec. 31, 2013

Dec. 31, 2013

Mar. 31, 2014

Dec. 31, 2013

Mar. 31, 2014

Dec. 31, 2013

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2014

Dec. 31, 2013

Dec. 31, 2013

Mar. 31, 2014

Mar. 31, 2014

Dec. 31, 2013

Dec. 31, 2013

Mar. 31, 2014

Mar. 31, 2014

Dec. 31, 2013

Dec. 31, 2013

Mar. 31, 2014

Mar. 31, 2014

Dec. 31, 2013

Mar. 31, 2014

Feb. 05, 2014

Dec. 31, 2013

Feb. 05, 2013

Dec. 31, 2013

Mar. 31, 2014

Dec. 31, 2013

USD ($)

JPY (¥)

USD ($)

JPY (¥)

Multi-currency uncommitted shelf facility, U.S. dollar denominated 1 [Member]

Multi-currency uncommitted shelf facility, U.S. dollar denominated 1 [Member]

Multi-currency uncommitted shelf facility, U.S. dollar denominated 2 [Member]

Multi-currency uncommitted shelf facility, U.S. dollar denominated 2 [Member]

Multi-currency uncommitted shelf facility, total U.S. dollar-denominated debt [Member]

Multi-currency uncommitted shelf facility, Japanese yen denominated 1 [Member]

Multi-currency uncommitted shelf facility, Japanese yen denominated 1 [Member]

Multi-currency uncommitted shelf facility, Japanese yen denominated 1 [Member]

Multi-currency uncommitted shelf facility, Japanese yen denominated 1 [Member]

Multi-currency uncommitted shelf facility, Japanese yen denominated 2 [Member]

Multi-currency uncommitted shelf facility, Japanese yen denominated 2 [Member]

Multi-currency uncommitted shelf facility, Japanese yen denominated 2 [Member]

Multi-currency uncommitted shelf facility, Japanese yen denominated 2 [Member]

Multi-currency uncommitted shelf facility, Japanese yen denominated 3 [Member]

Multi-currency uncommitted shelf facility, Japanese yen denominated 3 [Member]

Multi-currency uncommitted shelf facility, Japanese yen denominated 3 [Member]

Multi-currency uncommitted shelf facility, Japanese yen denominated 3 [Member]

Multi-currency uncommitted shelf facility, total Japanese yen-denominated debt [Member]

Committed loan, U.S. dollar denominated [Member]

Committed loan, U.S. dollar denominated [Member]

Revolving credit facility [Member]

Revolving credit facility [Member]

Revolving credit facility [Member]

Revolving credit facility [Member]

Multi-currency uncommitted shelf facility Japanese Yen Denominated 4 [Member]

Revolving Credit Facility Member [Member]

Uncommitted Multi Currency Shelf Facility Member [Member]

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

JPY (¥)

USD ($)

JPY (¥)

USD ($)

JPY (¥)

USD ($)

JPY (¥)

USD ($)

JPY (¥)

USD ($)

JPY (¥)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

USD ($)

Debt Instrument [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Original principal amount - facilities

'

¥ 8,000,000,000

'

'

$40,000,000

'

$20,000,000

'

'

'

¥ 3,100,000,000

'

'

'

¥ 2,300,000,000

'

'

'

¥ 2,200,000,000

'

'

'

'

'

'

'

'

'

'

'

'

Balance - facilities

77,300,000

[1]

8,000,000,000

[1]

'

8,000,000,000

17,100,000

[1]

17,100,000

8,600,000

[1]

11,400,000

'

4,300,000

400,000,000

[1]

4,100,000

[1]

400,000,000

12,600,000

1,300,000,000

[1]

12,300,000

1,300,000,000

9,000,000

900,000,000

[1]

11,800,000

1,200,000,000

'

'

'

35,000,000

[1],[2],[3]

'

35,000,000

[1]

'

75,800,000

'

14,000,000

Interest rate - facilities (in hundredths)

1.70%

1.70%

'

'

6.20%

'

6.20%

'

'

1.70%

1.70%

'

'

2.60%

2.60%

'

'

3.30%

3.30%

'

'

'

'

'

'

'

'

'

'

'

'

Repayment terms

'Notes due May 2022 with annual principal payments that begin in May 2016.

'Notes due May 2022 with annual principal payments that begin in May 2016.

'

'

'Notes due July 2016 with annual principal payments that began in July 2010.

'

'Notes due January 2017 with annual principal payments that began in January 2011.

'

'

'Notes due April 2014 with annual principal payments that began in April 2008.

'Notes due April 2014 with annual principal payments that began in April 2008.

'

'

'Notes due September 2017 with annual principal payments that began in September 2011.

'Notes due September 2017 with annual principal payments that began in September 2011.

'

'

'Notes due January 2017 with annual principal payments that began in January 2011.

'Notes due January 2017 with annual principal payments that began in January 2011.

'

'

'

'

'

'Revolving line of credit.

[2]

'

'

'

'

'Revolving line of credit.

[2]

'

Balance - other borrowings

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

10,400,000

'

'

69,000,000

50,000,000

'

0

'

'

'

Interest rate description - other borrowings

'Variable 30 day: 0.5843%

'Variable 30 day: 0.5843%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'Variable 30 day: 0.66%

[2]

'

'

'

'

'

'

Interest rate - other borrowings (in hundredths)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

0.66%

[2]

'

'

'

'

'

'

Maturity Date

1-May-22

1-May-22

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Amortization per 30 days

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

[3]

'

'

'

'

'

'

Current portion of long-term debt

$88,031,000

'

$67,824,000

'

'

'

'

'

$8,600,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

[3]

'

[3]

'

'

'

'

'

$34,000,000

[2]

'

[1]

The current portion of the Companybs long-term debt (i.e. becoming due in the next 12 months) includes $10.9 million of the balance of its Japanese yen-denominated debt under the multi-currency uncommitted shelf facility, $8.6 million of the balance on its U.S. dollar denominated debt under the multi-currency uncommitted shelf facility, $15.0 million of the Companybs committed loan and $35.0 million of its revolving loan.

[2]

On February 5, 2013, the Company entered into a second amendment of the amended and restated credit agreement. The amendment increased the commitment amount from $25.0 million to $100.0 million from February 2013 to February 2014, after which the commitment amount returns to the current level over a three-month period.

[3]

The committed loan is secured by deeds of trust with respect to the Companybs corporate headquarters and distribution center in Provo, Utah.

REVISIONS_Details

REVISIONS (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2013
Sales Revenue, Goods, Gross	$671,061	$541,305
Selling Expense	313,101	233,094
Restatement Adjustment [Member]	'	'
Sales Revenue, Goods, Gross	'	8,800
Selling Expense	'	$8,800

SUBSEQUENT_EVENT_Details

SUBSEQUENT EVENT (Details) (USD $)	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Jul. 31, 2013	Jun. 30, 2012
In Millions, unless otherwise specified
Subsequent Event [Line Items]	'	'	'	'	'
Allowance Of Restricted Payments	$50	$100	$50	$15	$100